The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial

被引：0
|
作者：
Shabbir, S. [1 ]
Pouliquen, I. [2 ]
Bentley, J. H. [3 ]
Bradford, E. S. [4 ]
Kaisermann, M. C. [5 ]
Albayaty, M. [6 ]
机构：
[1] GSK, Clin Platforms & Sci PCPS, Global Clin Sci & Delivery GCSD R&D Projects, Stevenage, Herts, England
[2] GSK, Clin Pharmacol Modelling & Simulat, Uxbridge, Middx, England
[3] GSK, Clin Stat, Uxbridge, Middx, England
[4] GSK, Resp Therapeut Area, Res Triangle Pk, NC USA
[5] GSK, Resp Therapy Area, Collegeville, PA USA
[6] Northwick Pk Hosp & Clin Res Ctr, PAREXEL Early Phase Clin Unit, Harrow, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1311
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: A randomized, open-label, two-period, comparative crossover study
    Park, JY
    Kim, KA
    Park, PW
    Suh, KH
    Lee, GS
    CLINICAL THERAPEUTICS, 2004, 26 (12) : 2092 - 2101
  • [22] Relative Bioavailability Of Oral Apremilast Administered as a 40 mg Tablet versus Two 20 mg Capsules With or Without Food in Healthy Males
    Reyes, Josephine
    Bai, Hua
    Kong, Linghui
    Lau, Henry
    Larouche, Richard
    Laskin, Oscar
    Wu, Anfan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1344
  • [23] The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men
    Nilausen, Dorrit Ostergaard
    Zuiker, R. G. J. A.
    van Gerven, Joop
    CLINICAL THERAPEUTICS, 2011, 33 (10) : 1492 - 1502
  • [24] Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White Participants
    Liefaard, Lia
    Hajduk, Eva
    van den Berg, Frans
    Panoilia, Eirini
    Bouma, Gerben
    Lisi, Edoardo
    Srinivasan, Naren
    Cui, Yi
    Gross, Annette S.
    Tarzi, Ruth
    Marks, Daniel J. B.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (11): : 1284 - 1293
  • [25] Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers
    Zhang, Wenhui
    Tyrrell, Helen
    Ding, Han Ting
    Pulley, Jennifer
    Boruvka, Audrey
    Erickson, Rich
    Abouhossein, Mariam
    Ravanello, Renato
    Tang, Meina Tao
    ADVANCES IN THERAPY, 2021, 38 (05) : 2418 - 2434
  • [26] Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers
    Wenhui Zhang
    Helen Tyrrell
    Han Ting Ding
    Jennifer Pulley
    Audrey Boruvka
    Rich Erickson
    Mariam Abouhossein
    Renato Ravanello
    Meina Tao Tang
    Advances in Therapy, 2021, 38 : 2418 - 2434
  • [27] Pharmacokinetics, safety and tolerability of a novel 100 mg/h transdermal fentanyl patch co-administered with 100 mg oral naltrexone in healthy males.
    Lor, M
    Di Marco, M
    Marier, J
    Roux, L
    Will, N
    Saedder, EA
    Morelli, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P76 - P76
  • [28] The Relative Bioavailability Study and Fasting and Fed States Pharmacokinetics of Bicalutamide 50-mg Tablets in Healthy Chinese Volunteers
    Lu, H-M
    Ye, M.
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2012, 62 (01): : 18 - 21
  • [29] Evaluation of the Pharmacokinetic Interaction and Safety of Atogepant Co-Administered with Acetaminophen or Naproxen in Healthy Participants: A Randomized Trial
    Ramesh Boinpally
    John Spaventa
    Kayla Chen
    Matthew Butler
    Clinical Drug Investigation, 2021, 41 : 557 - 567
  • [30] Evaluation of the Pharmacokinetic Interaction and Safety of Atogepant Co-Administered with Acetaminophen or Naproxen in Healthy Participants: A Randomized Trial
    Boinpally, Ramesh
    Spaventa, John
    Chen, Kayla
    Butler, Matthew
    CLINICAL DRUG INVESTIGATION, 2021, 41 (06) : 557 - 567
12345